The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model.

The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model. — المؤلف: Ha, Chae-Myeong — JACC. Basic to translational science Feb 2019

المؤلف
Ha, Chae-Myeong
النشر
JACC. Basic to translational science Feb 2019
الوصف
38-40 p.